We maintain an active dialogue with our internal stakeholders, our employees and managers, to share with them the information necessary to integrate EHS considerations into all aspects of the business and their jobs and responsibilities. We communicate with EHS professionals at sites through meetings, e-mail, the intranet site and documents. These EHS professionals review and add value to the development of the Framework, including the Standards, guidelines and tools, to the Plan for Excellence, to target setting and to all aspects of the EHS programme.

Our external stakeholder meetings include representatives from academia, government, investors, customers and non-governmental organisations. Each year we give stakeholders the opportunity to review our programmes, reporting and progress against their expectations and provide us with suggestions for improvement.

We participate in many surveys of our EHS practices and performance for investment management companies and rating organisations. Business in the Environment rated GSK first in the pharmaceutical sector in the 2002 7th Index of Corporate Environmental Engagement. With a score of 96%, GSK was placed in the Premier League. We are included in the Dow Jones Sustainability Index and in the UK FTSE 4Good. GSK ranked fourth out of 22 in the pharmaceutical industry with a score of B- overall and B in environment performance by OEKOM, an investment rating agency in Germany. We work closely with major socially responsible investment groups in the UK.

In addition to the stakeholder dialogue conducted by Corporate Environment, Health and Safety on behalf of the corporation, many of our operations have continuing dialogue with their neighbours and communities; with regulators and local authorities; and with trade unions where workers are unionised.